Clinical trial
NovaTears® Observational Study NT-002
NCT02356341 is registered in ClinicalTrials.gov with Novaliq GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- NovaTears® Observational Study NT-002
- Lead sponsor
- Novaliq GmbH
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2015
- Completion date
- December 31, 2015
- Enrollment
- 72 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.